Saturday, 29 September 2012

New Diabetes Treatment Blocks VEGF-B Protein Signalling

From "Gizmag".

According to the World Health Organization, there are currently 347 million diabetics worldwide, with 90 percent of those people having type II diabetes specifically. It occurs when fat accumulates in places such as muscles, blood vessels and the heart, causing the cells in those areas to no longer be sufficiently responsive to insulin. This insulin resistance, in turn, causes blood glucose levels to rise to dangerous levels. Ultimately, it can result in things such as heart disease, strokes, blindness, kidney failure, and amputations. Fortunately, however, an international team of scientists has just announced a new way of treating the disease.

>> Read the original article

No comments:

Post a Comment

All feedback is welcome but offensive comments or those touting unproven products won't make it to the blog.